메뉴 건너뛰기




Volumn 3, Issue 4, 2004, Pages 194-204

Heart failure: An epidemic of the 21st century

Author keywords

Heart failure management; Heart failure treatment algorithms

Indexed keywords

ALDOSTERONE ANTAGONIST; BISOPROLOL; BUCINDOLOL; CANDESARTAN; CARVEDILOL; DIGITALIS; DIGOXIN; DIURETIC AGENT; INOTROPIC AGENT; LISINOPRIL; LOSARTAN; METOPROLOL; NESIRITIDE; VALSARTAN;

EID: 10644236415     PISSN: 1535282X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hpc.0000146867.90558.ca     Document Type: Review
Times cited : (12)

References (65)
  • 2
    • 0037206364 scopus 로고    scopus 로고
    • Long-term trends in the incidence of and survival with heart failure
    • Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347:1397-1402.
    • (2002) N Engl J Med , vol.347 , pp. 1397-1402
    • Levy, D.1    Kenchaiah, S.2    Larson, M.G.3
  • 3
    • 0032741126 scopus 로고    scopus 로고
    • Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: Prevalence and mortality in a population-based cohort
    • Vasan RS, Larson MG, Benjamin EJ, et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol. 1999;33:1948-1955.
    • (1999) J Am Coll Cardiol , vol.33 , pp. 1948-1955
    • Vasan, R.S.1    Larson, M.G.2    Benjamin, E.J.3
  • 4
    • 0037058826 scopus 로고    scopus 로고
    • Lifetime risk for developing congestive heart failure: The Framingham Heart Study
    • Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106:3068-3072.
    • (2002) Circulation , vol.106 , pp. 3068-3072
    • Lloyd-Jones, D.M.1    Larson, M.G.2    Leip, E.P.3
  • 5
    • 0030002580 scopus 로고    scopus 로고
    • The progression from hypertension to congestive heart failure
    • Levy D, Larson MG, Vasan RS, et al. The progression from hypertension to congestive heart failure. JAMA. 1996;275:1557-1562.
    • (1996) JAMA , vol.275 , pp. 1557-1562
    • Levy, D.1    Larson, M.G.2    Vasan, R.S.3
  • 6
    • 0029793195 scopus 로고    scopus 로고
    • The role of hypertension in the pathogenesis of heart failure: A clinical mechanistic overview
    • Vasan RS, Levy D. The role of hypertension in the pathogenesis of heart failure: a clinical mechanistic overview. Arch Intern Med. 1996;156:1789-1796.
    • (1996) Arch Intern Med , vol.156 , pp. 1789-1796
    • Vasan, R.S.1    Levy, D.2
  • 7
    • 0030744599 scopus 로고    scopus 로고
    • Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension: SHEP Cooperative Research Group
    • Kostis JB, Davis BR, Cutler J, et al. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension: SHEP Cooperative Research Group. JAMA. 1997;278:212-216.
    • (1997) JAMA , vol.278 , pp. 212-216
    • Kostis, J.B.1    Davis, B.R.2    Cutler, J.3
  • 8
    • 0036681988 scopus 로고    scopus 로고
    • Obesity and the risk of heart failure
    • Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305-313.
    • (2002) N Engl J Med , vol.347 , pp. 305-313
    • Kenchaiah, S.1    Evans, J.C.2    Levy, D.3
  • 9
    • 0025688110 scopus 로고
    • Smoking and hypertension as predictors of cardiovascular risk in population studies
    • Kannel WB, Higgins M. Smoking and hypertension as predictors of cardiovascular risk in population studies. J Hypertens Suppl. 1990;8:S3-8.
    • (1990) J Hypertens Suppl , vol.8
    • Kannel, W.B.1    Higgins, M.2
  • 10
    • 0141468244 scopus 로고    scopus 로고
    • Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
    • Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154-2169.
    • (2003) Circulation , vol.108 , pp. 2154-2169
    • Sarnak, M.J.1    Levey, A.S.2    Schoolwerth, A.C.3
  • 11
    • 0035846616 scopus 로고    scopus 로고
    • ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
    • (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the International Society for Heart and Lung Transplantation; endorsed by the Heart Failure Society of America
    • Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the International Society for Heart and Lung Transplantation; endorsed by the Heart Failure Society of America. Circulation. 2001;104:2996-3007.
    • (2001) Circulation , vol.104 , pp. 2996-3007
    • Hunt, S.A.1    Baker, D.W.2    Chin, M.H.3
  • 12
    • 3342950243 scopus 로고    scopus 로고
    • New guidelines of the Joint National Committee (USA) on Prevention, Diagnosis and Management of Hypertension: From JNC VI to JNC VII
    • Britov AN, Bystrova MM. [New guidelines of the Joint National Committee (USA) on Prevention, Diagnosis and Management of Hypertension: from JNC VI to JNC VII]. Kardiologiia. 2003;43:93-97.
    • (2003) Kardiologiia , vol.43 , pp. 93-97
    • Britov, A.N.1    Bystrova, M.M.2
  • 13
    • 0026695294 scopus 로고
    • The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure
    • Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol. 1992;20:248-254.
    • (1992) J Am Coll Cardiol , vol.20 , pp. 248-254
    • Packer, M.1
  • 14
    • 0034990519 scopus 로고    scopus 로고
    • B-type natriuretic peptide levels: A potential novel "white count" for congestive heart failure
    • Maisel A. B-type natriuretic peptide levels: a potential novel "white count" for congestive heart failure. J Card Fail. 2001;7:183-193.
    • (2001) J Card Fail , vol.7 , pp. 183-193
    • Maisel, A.1
  • 15
    • 0037130155 scopus 로고    scopus 로고
    • Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure
    • Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161-167.
    • (2002) N Engl J Med , vol.347 , pp. 161-167
    • Maisel, A.S.1    Krishnaswamy, P.2    Nowak, R.M.3
  • 16
    • 0033517302 scopus 로고    scopus 로고
    • The effect of spironolactone on morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation Study Investigators
    • Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709-717.
    • (1999) N Engl J Med , vol.341 , pp. 709-717
    • Pitt, B.1    Zannad, F.2    Remme, W.J.3
  • 17
    • 0023266532 scopus 로고
    • Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS): The CONSENSUS Trial Study Group
    • Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS): the CONSENSUS Trial Study Group. N Engl J Med. 1987;316:1429-1435.
    • (1987) N Engl J Med , vol.316 , pp. 1429-1435
  • 18
    • 0033501328 scopus 로고    scopus 로고
    • Perindopril for elderly people with chronic heart failure: The PEP-CHF study: The PEP investigators
    • Cleland JG, Tendera M, Adamus J, et al. Perindopril for elderly people with chronic heart failure: the PEP-CHF study: the PEP investigators. Eur J Heart Fail. 1999;1:211-217.
    • (1999) Eur J Heart Fail , vol.1 , pp. 211-217
    • Cleland, J.G.1    Tendera, M.2    Adamus, J.3
  • 19
    • 0026785561 scopus 로고
    • Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
    • The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685-691.
    • (1992) N Engl J Med , vol.327 , pp. 685-691
  • 20
    • 0025913812 scopus 로고
    • Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
    • The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
    • (1991) N Engl J Med , vol.325 , pp. 293-302
  • 21
    • 0033534085 scopus 로고    scopus 로고
    • Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure: ATLAS Study Group
    • Packer M, Poole-Wilson PA, Armstrong PW, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure: ATLAS Study Group. Circulation. 1999;100:2312-2318.
    • (1999) Circulation , vol.100 , pp. 2312-2318
    • Packer, M.1    Poole-Wilson, P.A.2    Armstrong, P.W.3
  • 22
    • 0028955321 scopus 로고
    • Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure: Collaborative Group on ACE Inhibitor Trials
    • Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure: Collaborative Group on ACE Inhibitor Trials. JAMA. 1995;273:1450-1456.
    • (1995) JAMA , vol.273 , pp. 1450-1456
    • Garg, R.1    Yusuf, S.2
  • 23
    • 0031050642 scopus 로고    scopus 로고
    • Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease
    • Australia/New Zealand Heart Failure Research Collaborative Group. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet. 1997;349:375-380.
    • (1997) Lancet , vol.349 , pp. 375-380
  • 24
    • 10544231452 scopus 로고    scopus 로고
    • Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure: US Carvedilol Heart Failure Study Group
    • Colucci WS, Packer M, Bristow MR, et al. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure: US Carvedilol Heart Failure Study Group. Circulation. 1996;94:2800-2806.
    • (1996) Circulation , vol.94 , pp. 2800-2806
    • Colucci, W.S.1    Packer, M.2    Bristow, M.R.3
  • 25
    • 0029937949 scopus 로고    scopus 로고
    • The effect of carvedilol on morbidity and mortality in patients with chronic heart failure: U.S. Carvedilol Heart Failure Study Group
    • Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure: U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334:1349-1355.
    • (1996) N Engl J Med , vol.334 , pp. 1349-1355
    • Packer, M.1    Bristow, M.R.2    Cohn, J.N.3
  • 26
    • 10544251442 scopus 로고    scopus 로고
    • Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure: The PRECISE Trial: Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise
    • Packer M, Colucci WS, Sackner-Bernstein JD, et al. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure: the PRECISE Trial: Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise. Circulation. 1996;94:2793-2799.
    • (1996) Circulation , vol.94 , pp. 2793-2799
    • Packer, M.1    Colucci, W.S.2    Sackner-Bernstein, J.D.3
  • 27
    • 0035195529 scopus 로고    scopus 로고
    • Aspirin impairs reverse myocardial remodeling in patients with heart failure treated with beta-blockers
    • Lindenfeld J, Robertson AD, Lowes BD, et al. Aspirin impairs reverse myocardial remodeling in patients with heart failure treated with beta-blockers. J Am Coll Cardiol. 2001;38:1950-1956.
    • (2001) J Am Coll Cardiol , vol.38 , pp. 1950-1956
    • Lindenfeld, J.1    Robertson, A.D.2    Lowes, B.D.3
  • 28
    • 0033549290 scopus 로고    scopus 로고
    • Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
    • Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001-2007.
    • (1999) Lancet , vol.353 , pp. 2001-2007
  • 29
    • 0033514046 scopus 로고    scopus 로고
    • The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
    • The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353:9-13.
    • (1999) Lancet , vol.353 , pp. 9-13
  • 30
    • 0035978801 scopus 로고    scopus 로고
    • A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure
    • A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med. 2001;344:1659-1667.
    • (2001) N Engl J Med , vol.344 , pp. 1659-1667
  • 31
    • 3142776467 scopus 로고    scopus 로고
    • Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): Randomised controlled trial
    • Poole-Wilson PA, Swedberg K, Cleland JG, et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet. 2003;362:7-13.
    • (2003) Lancet , vol.362 , pp. 7-13
    • Poole-Wilson, P.A.1    Swedberg, K.2    Cleland, J.G.3
  • 32
    • 0027135308 scopus 로고
    • Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy: Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group
    • Waagstein F, Bristow MR, Swedberg K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy: Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet. 1993;342:1441-1446.
    • (1993) Lancet , vol.342 , pp. 1441-1446
    • Waagstein, F.1    Bristow, M.R.2    Swedberg, K.3
  • 33
    • 0030902115 scopus 로고    scopus 로고
    • Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
    • Pitt B, Segal R, Martinez FA, et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet. 1997;349:747-752.
    • (1997) Lancet , vol.349 , pp. 747-752
    • Pitt, B.1    Segal, R.2    Martinez, F.A.3
  • 34
    • 0034612118 scopus 로고    scopus 로고
    • Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomised trial: The Losartan Heart Failure Survival Study ELITE II
    • Pitt B, Poole-Wilson PA, Segal R, et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial: the Losartan Heart Failure Survival Study ELITE II. Lancet. 2000;355:1582-1587.
    • (2000) Lancet , vol.355 , pp. 1582-1587
    • Pitt, B.1    Poole-Wilson, P.A.2    Segal, R.3
  • 35
    • 0037027511 scopus 로고    scopus 로고
    • Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: The Valsartan Heart Failure Trial (Val-HeFT)
    • Latini R, Masson S, Anand I, et al. Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT). Circulation. 2002;106:2454-2458.
    • (2002) Circulation , vol.106 , pp. 2454-2458
    • Latini, R.1    Masson, S.2    Anand, I.3
  • 36
    • 0037120958 scopus 로고    scopus 로고
    • Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors
    • Maggioni AP, Anand I, Gottlieb SO, et al. Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors. J Am Coll Cardiol. 2002;40:1414-1421.
    • (2002) J Am Coll Cardiol , vol.40 , pp. 1414-1421
    • Maggioni, A.P.1    Anand, I.2    Gottlieb, S.O.3
  • 37
    • 0042410539 scopus 로고    scopus 로고
    • Effects of candesartan on mortality and morbidity in patients with chronic heart failure: The CHARM-Overall programme
    • Pfeffer MA, Swedberg K, Granger CB, et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet. 2003;362:759-766.
    • (2003) Lancet , vol.362 , pp. 759-766
    • Pfeffer, M.A.1    Swedberg, K.2    Granger, C.B.3
  • 38
    • 0041408234 scopus 로고    scopus 로고
    • Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved Trial
    • Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003;362:777-781.
    • (2003) Lancet , vol.362 , pp. 777-781
    • Yusuf, S.1    Pfeffer, M.A.2    Swedberg, K.3
  • 39
    • 0041909380 scopus 로고    scopus 로고
    • Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: The CHARM-Alternative trial
    • Granger CB, McMurray JJ, Yusuf S, et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet. 2003;362:772-776.
    • (2003) Lancet , vol.362 , pp. 772-776
    • Granger, C.B.1    McMurray, J.J.2    Yusuf, S.3
  • 40
    • 0041408235 scopus 로고    scopus 로고
    • Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: The CHARM-Added trial
    • McMurray JJ, Ostergren J, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet. 2003;362:767-771.
    • (2003) Lancet , vol.362 , pp. 767-771
    • McMurray, J.J.1    Ostergren, J.2    Swedberg, K.3
  • 41
    • 0242490542 scopus 로고    scopus 로고
    • Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
    • Pfeffer MA, McMurray JJ, Velazquez EJ, et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med. 2003;349:1893-1906.
    • (2003) N Engl J Med , vol.349 , pp. 1893-1906
    • Pfeffer, M.A.1    McMurray, J.J.2    Velazquez, E.J.3
  • 42
    • 0027297873 scopus 로고
    • Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure: The V-HeFT VA Cooperative Studies Group
    • Loeb HS, Johnson G, Henrick A, et al. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure: the V-HeFT VA Cooperative Studies Group. Circulation. 1993;87(6 suppl):VI78-87.
    • (1993) Circulation , vol.87 , Issue.6 SUPPL.
    • Loeb, H.S.1    Johnson, G.2    Henrick, A.3
  • 43
    • 0036023202 scopus 로고    scopus 로고
    • African-American Heart Failure Trial (A-HeFT): Rationale, design, and methodology
    • Franciosa JA, Taylor AL, Cohn JN, et al. African-American Heart Failure Trial (A-HeFT): rationale, design, and methodology. J Card Fail. 2002;8:128-135.
    • (2002) J Card Fail , vol.8 , pp. 128-135
    • Franciosa, J.A.1    Taylor, A.L.2    Cohn, J.N.3
  • 44
    • 0036729830 scopus 로고    scopus 로고
    • The African-American Heart Failure Trial: Background, rationale and significance
    • Taylor AL, Cohn JN, Worcel M, et al. The African-American Heart Failure Trial: background, rationale and significance. J Natl Med Assoc. 2002;94:762-769.
    • (2002) J Natl Med Assoc , vol.94 , pp. 762-769
    • Taylor, A.L.1    Cohn, J.N.2    Worcel, M.3
  • 45
    • 0031051347 scopus 로고    scopus 로고
    • The effect of digoxin on mortality and morbidity in patients with heart failure
    • Garg R, Gorlin R, Smith T, et al. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997;336:525-533.
    • (1997) N Engl J Med , vol.336 , pp. 525-533
    • Garg, R.1    Gorlin, R.2    Smith, T.3
  • 46
    • 0342378157 scopus 로고    scopus 로고
    • Patients with mild heart failure worsen during withdrawal from digoxin therapy
    • Adams KF Jr, Gheorghiade M, Uretsky BF, et al. Patients with mild heart failure worsen during withdrawal from digoxin therapy. J Am Coll Cardiol. 1997;30:42-48.
    • (1997) J Am Coll Cardiol , vol.30 , pp. 42-48
    • Adams Jr., K.F.1    Gheorghiade, M.2    Uretsky, B.F.3
  • 47
    • 0027216221 scopus 로고
    • Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors: RADIANCE Study
    • Packer M, Gheorghiade M, Young JB, et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors: RADIANCE Study. N Engl J Med. 1993;329:1-7.
    • (1993) N Engl J Med , vol.329 , pp. 1-7
    • Packer, M.1    Gheorghiade, M.2    Young, J.B.3
  • 48
    • 0037071808 scopus 로고    scopus 로고
    • Cardiac resynchronization in chronic heart failure
    • Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845-1853.
    • (2002) N Engl J Med , vol.346 , pp. 1845-1853
    • Abraham, W.T.1    Fisher, W.G.2    Smith, A.L.3
  • 49
    • 0037638884 scopus 로고    scopus 로고
    • Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial
    • Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003;289:2685-2694.
    • (2003) JAMA , vol.289 , pp. 2685-2694
    • Young, J.B.1    Abraham, W.T.2    Smith, A.L.3
  • 50
    • 2442479695 scopus 로고    scopus 로고
    • Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
    • Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-2150.
    • (2004) N Engl J Med , vol.350 , pp. 2140-2150
    • Bristow, M.R.1    Saxon, L.A.2    Boehmer, J.3
  • 51
    • 0037307437 scopus 로고    scopus 로고
    • Comparison of medical therapy, pacing and defibrillation in heart failure (COMPANION) trial terminated early; combined biventricular pacemaker- defibrillators reduce all-cause mortality and hospitalization
    • Salukhe TV, Francis DP, Sutton R. Comparison of medical therapy, pacing and defibrillation in heart failure (COMPANION) trial terminated early; combined biventricular pacemaker-defibrillators reduce all-cause mortality and hospitalization. Int J Cardiol. 2003;87:119-120.
    • (2003) Int J Cardiol , vol.87 , pp. 119-120
    • Salukhe, T.V.1    Francis, D.P.2    Sutton, R.3
  • 52
    • 0006918490 scopus 로고    scopus 로고
    • Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia: Multicenter Automatic Defibrillator Implantation Trial Investigators
    • Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia: Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335:1933-1940.
    • (1996) N Engl J Med , vol.335 , pp. 1933-1940
    • Moss, A.J.1    Hall, W.J.2    Cannom, D.S.3
  • 53
    • 0037149716 scopus 로고    scopus 로고
    • Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction
    • Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
    • (2002) N Engl J Med , vol.346 , pp. 877-883
    • Moss, A.J.1    Zareba, W.2    Hall, W.J.3
  • 54
    • 2442572117 scopus 로고    scopus 로고
    • Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy
    • Kadish A, Dyer A, Daubert JP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151-2158.
    • (2004) N Engl J Med , vol.350 , pp. 2151-2158
    • Kadish, A.1    Dyer, A.2    Daubert, J.P.3
  • 56
    • 0031038213 scopus 로고    scopus 로고
    • Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT: European Myocardial Infarct Amiodarone Trial Investigators
    • Julian DG, Camm AJ, Frangin G, et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT: European Myocardial Infarct Amiodarone Trial Investigators. Lancet. 1997;349:667-674.
    • (1997) Lancet , vol.349 , pp. 667-674
    • Julian, D.G.1    Camm, A.J.2    Frangin, G.3
  • 57
    • 0031029373 scopus 로고    scopus 로고
    • Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT: Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators
    • Cairns JA, Connolly SJ, Roberts R, et al. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT: Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet. 1997;349:675-682.
    • (1997) Lancet , vol.349 , pp. 675-682
    • Cairns, J.A.1    Connolly, S.J.2    Roberts, R.3
  • 58
    • 0029004921 scopus 로고
    • Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia: Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure
    • Singh SN, Fletcher RD, Fisher SG, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia: Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med. 1995;333:77-82.
    • (1995) N Engl J Med , vol.333 , pp. 77-82
    • Singh, S.N.1    Fletcher, R.D.2    Fisher, S.G.3
  • 59
    • 0027998462 scopus 로고
    • Randomised trial of low-dose amiodarone in severe congestive heart failure: Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)
    • Doval HC, Nul DR, Grancelli HO, et al. Randomised trial of low-dose amiodarone in severe congestive heart failure: Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet. 1994;344:493-498.
    • (1994) Lancet , vol.344 , pp. 493-498
    • Doval, H.C.1    Nul, D.R.2    Grancelli, H.O.3
  • 60
    • 0037028593 scopus 로고    scopus 로고
    • A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission
    • Kasper EK, Gerstenblith G, Hefter G, et al. A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission. J Am Coll Cardiol. 2002;39:471-480.
    • (2002) J Am Coll Cardiol , vol.39 , pp. 471-480
    • Kasper, E.K.1    Gerstenblith, G.2    Hefter, G.3
  • 61
    • 0036399630 scopus 로고    scopus 로고
    • Randomized, controlled trial of integrated heart failure management: The Auckland Heart Failure Management Study
    • Doughty RN, Wright SP, Pearl A, et al. Randomized, controlled trial of integrated heart failure management: the Auckland Heart Failure Management Study. Eur Heart J. 2002;23:139-146.
    • (2002) Eur Heart J , vol.23 , pp. 139-146
    • Doughty, R.N.1    Wright, S.P.2    Pearl, A.3
  • 62
    • 0037005834 scopus 로고    scopus 로고
    • Randomized trial of an education and support intervention to prevent readmission of patients with heart failure
    • Krumholz HM, Amatruda J, Smith GL, et al. Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol. 2002;39:83-89.
    • (2002) J Am Coll Cardiol , vol.39 , pp. 83-89
    • Krumholz, H.M.1    Amatruda, J.2    Smith, G.L.3
  • 63
    • 0034645546 scopus 로고    scopus 로고
    • Effectiveness of team-managed home-based primary care: A randomized multicenter trial
    • Hughes SL, Weaver FM, Giobbie-Hurder A, et al. Effectiveness of team-managed home-based primary care: a randomized multicenter trial. JAMA. 2000;284:2877-2885.
    • (2000) JAMA , vol.284 , pp. 2877-2885
    • Hughes, S.L.1    Weaver, F.M.2    Giobbie-Hurder, A.3
  • 64
    • 0035978763 scopus 로고    scopus 로고
    • Effect of carvedilol on survival in severe chronic heart failure
    • Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651-1658.
    • (2001) N Engl J Med , vol.344 , pp. 1651-1658
    • Packer, M.1    Coats, A.J.2    Fowler, M.B.3
  • 65
    • 0037149716 scopus 로고    scopus 로고
    • Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction
    • Multicenter Automatic Defibrillator Implantation Trial II Investigators
    • Moss AJ, Zareba W, Hall WJ, et al. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
    • (2002) N Engl J Med , vol.346 , pp. 877-883
    • Moss, A.J.1    Zareba, W.2    Hall, W.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.